Stockscreener 앱 받기
11.35
8.10%
-1.00
시간 외 거래:
11.35
Benitec Biopharma Inc (BNTC) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | 0.007 | 0.054 |
Operating Expenses
|
40.22%
4.141
|
6.927 | 5.874 | 4.557 | 4.395 |
| Operating Income/Loss |
40.22%
-4.141
|
-6.927 | -5.874 | -4.55 | -4.341 |
| Nonoperating Income/Loss |
206.98%
-0.138
|
0.129 | -0.08 | -0.111 | -0.056 |
| Income/Loss From Continuing Operations Before Tax |
37.06%
-4.279
|
-6.798 | -5.954 | 0.007 | 0.054 |
| Income/Loss From Continuing Operations After Tax |
37.06%
-4.279
|
-6.798 | -5.954 | -4.661 | -4.397 |
|
Net Income/Loss
|
37.06%
-4.279
|
-6.798 | -5.954 | -4.661 | -4.397 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.55%
2.6163
|
2.5763 | 2.1571 | -20.70 | 27.98 |
| Diluted Average Shares |
1.55%
2.6163
|
2.5763 | 2.1571 | -20.70 | 27.98 |
| Basic Earnings Per Share |
37.88%
-1.64
|
-2.64 | -2.76 | -13.45 | -0.16 |
| Diluted Earnings Per Share |
37.88%
-1.64
|
-2.64 | -2.76 | -13.45 | -0.16 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.11%
1.70%
자본화:
|
볼륨(24시간):